Navigation Links
Kessler Foundation study provides first Class 1 evidence for cognitive rehabilitation in MS
Date:11/21/2013

WEST ORANGE, NJ November 21, 2013. Kessler Foundation researchers published the results of the MEMREHAB Trial in Neurology, the medical journal of the American Academy of Neurology, providing the first Class I evidence for the efficacy of cognitive rehabilitation in multiple sclerosis (MS). The article, Chiaravalloti N, Moore NB, Nikelshpur OM, DeLuca D: An RCT to treat learning impairment in MS. Neurology 2013(81), was released as an epub ahead of print on November 8. It was accompanied by an editorial: Filippi M, Rocca MA: Let's rehabilitate cognitive rehabilitation for MS. Neurology 2013(81):1-2.

Although disabling cognitive problems that affect functional performance and employment are common in persons with MS, there are very few evidence-based protocols for cognitive rehabilitation in MS. This randomized controlled trial (RCT) is the first to include both objective (investigator administered) and subjective measures (patient and family self-report). Investigators looked at the impact of the modified Story Memory Technique (mSMT) on learning and memory in 86 participants with MS with documented memory deficits (41 mSMT group, 45 placebo). Not only did objective measures improve, patients and families reported improvements in daily function in everyday life - improvements that had a positive impact on satisfaction with life and everyday contentment.

"Our results show that cognitive rehabilitation works," said Nancy Chiaravalloti, Ph.D., director of Neuroscience & Neuropsychology Research at Kessler Foundation, "and moreover, the effects of the 10-session protocol persisted for six months." a unique aspect of the protocol is the inclusion of 2 sessions that focus on translating cognitive strategies to daily life. Neuroimaging results that were collected in a subset of patients were published in the Journal of Neurology in 2012 (Chiaravalloti N, et al. Increased cerebral activation after behavioral treatment for memory deficits in MS. J Neurol 2012;259:1337-46). FMRI supported the clinical results, as evidenced by changes in brain activation, noted Dr. Chiaravalloti.

The two studies are being used to support reimbursement for cognitive rehabilitation. "RCTs are essential to demonstrating to third party payers that cognitive rehabilitation should be a reimbursable intervention," commented John DeLuca, Ph.D., VP of Research & Training at Kessler Foundation. "Behavioral intervention should be available for persons with MS who have memory deficits. Without reimbursement, however, few clinicians will use it and few patients will benefit."

The mSMT protocol has been translated into Spanish and is being used in the U.S., Mexico, and Argentina. A Chinese translation has also been completed for use in upcoming studies. Future studies will consider other factors such as type of MS, the duration of MS, and level of cognitive reserve.


'/>"/>

Contact: Carolann Murphy
CMurphy@kesslerfoundaiton.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. Kessler researchers find aerobic exercise benefits memory in persons with multiple sclerosis
2. Kessler Foundation researcher reports pilot results from a virtual reality executive function task
3. Kessler Foundation fellow receives grant from National Institutes of Health
4. Kessler Foundation awarded more than $500,000 in grants by NJ Commission on Brain Injury Research
5. Kessler Foundations Elaine Katz presents at national summit on disability employment
6. Kessler Foundation participates in multi-site NIH study to develop caregiver TBI-CareQOL
7. Kessler Foundations James Sumowski, Ph.D., speaks at April 18-19 MS Symposium in Toronto
8. Dr. DeLuca of Kessler Foundation speaks at Consortium of MS Centers meeting in Chicago
9. Kessler Foundation scientists receive Consortium of MS Centers grant to study emotional processing
10. Kessler Foundation scientist receives National MS Society grant for predictors of memory decline
11. Kessler Foundation scientist receives National MS Society grant for new memory study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2019)... DETROIT (PRWEB) , ... June 25, 2019 , ... Women’s ... and raised in Louisiana and has been a practicing midwife for over 3 years. ... years. April received her Master’s in Nursing from Frontier University and her undergraduate from ...
(Date:6/25/2019)... ... June 25, 2019 , ... Smile Brands Inc., one of ... than 400 affiliated offices across 17 states, is pleased to announce its latest ... will provide full-service administrative support to the practice, which includes purchasing, payroll, accounting, ...
(Date:6/25/2019)... ... June 25, 2019 , ... The Global Smile Foundation will ... July thanks to 15-year-old Kylie Azizzadeh’s efforts fundraising for the mission. She has already ... before the mission takes place on July 15, 2019. , In 2018, Kylie ...
(Date:6/24/2019)... ... 2019 , ... innovaTel Telepsychiatry, a leading provider of psychiatric ... Advisory Board (SAB) to help inform the Company’s efforts to bring telepsychiatry services ... , We are honored to announce that Linda Rosenberg, immediate past President and ...
(Date:6/24/2019)... (PRWEB) , ... June 24, 2019 , ... Exercising on ... cardio, people often try to mitigate this by running on softer surfaces, such as ... made of a rubber composite. Why not be able to have shock-absorption benefits ...
Breaking Medicine News(10 mins):
(Date:6/19/2019)... , ... June 19, 2019 , ... ... exclusively for the promotion of social welfare and protection of physicians’ rights, asserts ... than the previous revision and still rely on narrow guidelines as a basis ...
(Date:6/19/2019)... ... June 19, 2019 , ... Center for Vein Restoration (CVR) CEO and Founder, ... CEOs in 2019 . Glassdoor , one of the world’s largest job ... leaders that employees love working for throughout North America and parts of Europe. Dr. ...
(Date:6/19/2019)... Pa. (PRWEB) , ... June 19, 2019 , ... ... nuclear receptor and in vitro toxicology testing solutions, announced the addition of the ... kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers to perform ...
Breaking Medicine Technology: